Latest Intelligence on Therapy Area in Switzerland

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Novartis: promising results for Diovan

Published By Datamonitor
11 Apr 2001
CommentWire
CommentWire

Novartis: GIST falls under Gleevec's spell

Published By Datamonitor
21 May 2001
CommentWire
CommentWire

Novartis: a small setback for Gleevec

Published By Datamonitor
25 Jun 2001
CommentWire
CommentWire

Biogen/Serono: pistols at dawn

Published By Datamonitor
29 Jun 2001
CommentWire
CommentWire

Roche: building a strong hepatitis C portfolio

Published By Datamonitor
03 Jul 2001
CommentWire
CommentWire

Debiopharm: a bleak future for Trelstar

Published By Datamonitor
09 Jul 2001
CommentWire
CommentWire

Roche/Schering-Plough: competing in drug markets, not courts

Published By Datamonitor
14 Aug 2001
CommentWire
CommentWire

Roche: HIV announcement to dispel pipeline fears

Published By Datamonitor
21 Aug 2001
CommentWire
CommentWire

Roche: stopping Xenical from slimming down

Published By Datamonitor
10 Oct 2001
CommentWire
CommentWire

Novartis: educating Americans on Exelon

Published By Datamonitor
18 Oct 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | » »|

No help is available.